CIPHER PHARMACEUTICALS INC (CPH.CA) Stock Income Statement
TSX:CPH - CA17253X1050 - Common Stock
15.3 CAD
+0.31 (+2.07%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 47.59M | 33.36M | 21.16M | 20.68M | 21.94M | |||
| Cost Of Goods | 12.48M | 9.26M | 4.07M | 3.99M | 3.68M | |||
| Gross Profit | 35.12M | 24.10M | 17.09M | 16.68M | 18.26M | |||
| Operating Expenses | 25.45M | 16.25M | 7.06M | 5.64M | 5.20M | |||
| Research and Development | 21.00K | 0.00 | 139.00K | 100.00K | 90.00K | |||
| Selling, General, and Administrative Expenses | 18.36M | 12.24M | 5.69M | 4.55M | 5.11M | |||
| Operating Income | 9.67M | 7.85M | 10.03M | 11.05M | 13.06M | |||
| Interest Income/Expense | -1.35M | -2.18M | 2.65M | 430.00K | 10.00K | |||
| Non Recurring Items | -2.56M | -2.71M | N/A | 0.00 | -1.25M | |||
| Income Before Taxes | 5.76M | 2.96M | 12.68M | 11.48M | 11.06M | |||
| Income Tax | -6.38M | -8.59M | -7.70M | -15.16M | 3.30M | |||
| Net Income | 12.14M | 11.54M | 20.38M | 26.64M | 7.76M | |||
| EBITDA | 16.73M | 11.87M | 11.26M | 12.04M | 13.76M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.45 | 0.46 | 0.80 | 1.03 | 0.29 | |||
| Non GAAP EPS | 0.46 | 0.45 | 0.79 | N/A | 0.31 | |||
| Statistics | ||||||||
| Gross Profit Margin | 73.79% | 72.24% | 80.77% | 80.66% | 83.23% | |||
| Profit Margin | 25.52% | 34.60% | 96.32% | 128.82% | 35.37% | |||
| Operating Profit Margin | 20.32% | 23.52% | 47.41% | 53.43% | 59.53% | |||
All data in USD